Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Other solid neoplasm 1

Conditions

Brain Neoplasms 362Glioblastoma 299Glioma 239Neuroblastoma 95Neoplasms 70Central Nervous System Neoplasms 62Astrocytoma 61Meningioma 59Breast Neoplasms 51Lung Neoplasms 46Carcinoma, Non-Small-Cell Lung 46Melanoma 40Sarcoma 35Medulloblastoma 33Meningeal Carcinomatosis 32Recurrence 31Neoplasm Metastasis 28Diffuse Intrinsic Pontine Glioma 28Prostatic Neoplasms 27Pheochromocytoma 26Paraganglioma 26Neurofibromatosis 1 26Pancreatic Neoplasms 24Ovarian Neoplasms 24Oligodendroglioma 22Ependymoma 21Osteosarcoma 20Head and Neck Neoplasms 20Spinal Cord Neoplasms 19Kidney Neoplasms 19

Interventions

tovorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Low-grade Glioma × CNS × Clear all
NCT07441707 2026-06-01

A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours

Ipsen

Phase 1 Recruiting
6 enrolled
CNS

Low-grade Glioma

NCT04775485 2025-04-10

FIREFLY-1

Day One Biopharmaceuticals, Inc.

Phase 2 Recruiting
141 enrolled 1 FDA
CNSOther solid neoplasm

Low-grade Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡